Successful treatment of AIDS-related pulmonary Kaposi's sarcoma with liposomal daunorubicin

Eur Respir J. 1994 Apr;7(4):824-5. doi: 10.1183/09031936.94.07040824.

Abstract

We report a 35 year old male, human immunodeficiency virus (HIV)-infected patient with acquired immune deficiency syndrome (AIDS), who presented with rapidly progressive pulmonary Kaposi's sarcoma. The tumour regressed with treatment with liposomal daunorubicin and remained in partial remission until the patient died 12 months later from complications of HIV infection. Liposomal daunorubicin may be a safe and effective alternative to the treatment protocols in current use for pulmonary Kaposi's sarcoma.

Publication types

  • Case Reports

MeSH terms

  • Acquired Immunodeficiency Syndrome / complications*
  • Adult
  • Daunorubicin / administration & dosage*
  • Humans
  • Liposomes
  • Lung Neoplasms / diagnostic imaging
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / etiology
  • Male
  • Radiography
  • Sarcoma, Kaposi / diagnostic imaging
  • Sarcoma, Kaposi / drug therapy*
  • Sarcoma, Kaposi / etiology

Substances

  • Liposomes
  • Daunorubicin